Myriad Genetics reported $59.3M in Debt for its fiscal quarter ending in March of 2025.





Debt Change Date
Agilent USD 3.35B 0 Dec/2025
Becton, Dickinson and Co. USD 19.54B 358M Dec/2025
Bio-Rad Laboratories USD 1.39B 9.2M Dec/2025
Bruker USD 2.04B 34.4M Dec/2025
Danaher USD 18.48B 66M Mar/2026
Illumina USD 2.55B 23M Dec/2025
J&J USD 47.93B 2.14B Dec/2025
Mettler Toledo International USD 2.15B 57.69M Dec/2025
Myriad Genetics USD 59.3M 19.7M Mar/2025
OraSure Technologies USD 782K 465K Jun/2024
Pacific Biosciences Of California USD 892.24M 653K Dec/2023
Quest Diagnostics USD 6.41B 179M Mar/2026
Quidel USD 2.83B 9.9M Dec/2025
Repligen USD 546.58M 4.37M Mar/2026
Revvity USD 3.4B 29.2M Dec/2025
Standard Biotools USD 27.39M 1.23M Sep/2025
Thermo Fisher Scientific USD 39.39B 3.7B Dec/2025
Veracyte USD 39.65M 799K Dec/2025
Waters USD 1.49B 4.92M Dec/2025